JP2017514481A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514481A5
JP2017514481A5 JP2016565162A JP2016565162A JP2017514481A5 JP 2017514481 A5 JP2017514481 A5 JP 2017514481A5 JP 2016565162 A JP2016565162 A JP 2016565162A JP 2016565162 A JP2016565162 A JP 2016565162A JP 2017514481 A5 JP2017514481 A5 JP 2017514481A5
Authority
JP
Japan
Prior art keywords
binding
reagent
ligand
receptor molecule
target cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016565162A
Other languages
English (en)
Japanese (ja)
Other versions
JP6678593B2 (ja
JP2017514481A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/059510 external-priority patent/WO2015166049A1/en
Publication of JP2017514481A publication Critical patent/JP2017514481A/ja
Publication of JP2017514481A5 publication Critical patent/JP2017514481A5/ja
Application granted granted Critical
Publication of JP6678593B2 publication Critical patent/JP6678593B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016565162A 2014-04-30 2015-04-30 標的細胞を単離する方法 Active JP6678593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14166718 2014-04-30
EP14166718.8 2014-04-30
PCT/EP2015/059510 WO2015166049A1 (en) 2014-04-30 2015-04-30 Method of isolating a target cell

Publications (3)

Publication Number Publication Date
JP2017514481A JP2017514481A (ja) 2017-06-08
JP2017514481A5 true JP2017514481A5 (enExample) 2018-06-14
JP6678593B2 JP6678593B2 (ja) 2020-04-08

Family

ID=50693456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016565162A Active JP6678593B2 (ja) 2014-04-30 2015-04-30 標的細胞を単離する方法

Country Status (7)

Country Link
US (1) US11150239B2 (enExample)
EP (1) EP3137905B1 (enExample)
JP (1) JP6678593B2 (enExample)
CN (1) CN106662584B (enExample)
AU (1) AU2015254588B2 (enExample)
CA (1) CA2945414C (enExample)
WO (1) WO2015166049A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013124474A2 (en) 2012-02-23 2013-08-29 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
EP3132247B1 (en) * 2014-04-16 2021-08-18 Juno Therapeutics GmbH Methods, kits and apparatus for expanding a population of cells
EP3365678A1 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods for culturing cells and kits and apparatus for same
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
IL258844B2 (en) 2015-10-22 2024-03-01 Juno Therapeutics Gmbh Methods for culturing cells and kits and apparatus for same
EP4647493A3 (en) 2017-04-27 2026-01-14 Juno Therapeutics, Inc. Oligomeric particle reagents and methods of use thereof
KR102088277B1 (ko) * 2018-04-27 2020-03-13 주식회사 유니언스진 면역 화학 진단법을 이용한 표적 항원 검출용 종이기반 3차원 구조의 미세칩과 이를 이용한 표적항원 검출 방법
US20210206857A1 (en) * 2018-05-21 2021-07-08 Bioprocessia Technologies Llc Multivalent protein complexes
CN112805384A (zh) * 2018-07-17 2021-05-14 华盛顿大学 涉及基于适体的可逆细胞选择的组合物和方法
CA3108657A1 (en) 2018-08-09 2020-02-13 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
WO2020047363A1 (en) * 2018-08-31 2020-03-05 Busa William Methods for isolating target cells from blood
US12522660B2 (en) 2018-10-31 2026-01-13 C3S2 Gmbh Methods for selection and stimulation of cells and apparatus for same
US11965882B2 (en) 2020-01-31 2024-04-23 Cell.Copedia GmbH Methods of isolating a biological entity
WO2023017115A1 (en) * 2021-08-11 2023-02-16 Iba Lifesciences Gmbh Fractionation of cells based on a marker protein
EP4514944A1 (en) 2022-04-28 2025-03-05 Bio-ReCell Ltd. Method for separating target cells
WO2025238197A1 (en) * 2024-05-16 2025-11-20 Iba Lifesciences Gmbh Functionalized three-dimensional (3d) polymer scaffold for affinity chromatography

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2624470B2 (ja) 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
US4851341A (en) 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system
DE4237113B4 (de) 1992-11-03 2006-10-12 "Iba Gmbh" Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
AU5132096A (en) 1995-01-30 1996-08-21 Terrapin Technologies, Inc. Glubodies - multiplicities of proteins capable of binding a variety of small molecules
JPH11501008A (ja) 1995-02-09 1999-01-26 ユニバーシティ オブ ワシントン 改変−アフィニティーストレプトアビジン
WO1997011183A1 (en) 1995-04-11 1997-03-27 Trustees Of Boston University Streptavidin mutants
DE19641876B4 (de) 1996-10-10 2011-09-29 Iba Gmbh Streptavidinmuteine
EP0977770A4 (en) 1997-03-14 2000-04-05 Univ Boston DIFFERENTLY FLAVORED STREPTAVIDINE
US5985658A (en) 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
EP1227321A1 (en) 2000-12-28 2002-07-31 Institut für Bioanalytik GmbH Reversible MHC multimer staining for functional purification of antigen-specific T cells
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
WO2003029462A1 (en) 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
US8299782B2 (en) 2005-04-19 2012-10-30 Panasonic Corporation Position sensor, optical head device, head moving mechanism, information recording and reproduction device and position control system
EP2518193A3 (en) * 2006-11-15 2013-01-23 Invitrogen Dynal AS Methods for reversibly binding a biotin compound to a support
US8008032B2 (en) * 2008-02-25 2011-08-30 Cellective Dx Corporation Tagged ligands for enrichment of rare analytes from a mixed sample
WO2012044999A2 (en) * 2010-10-01 2012-04-05 Ludwig Institute For Cancer Research Ltd. Reversible protein multimers, methods for their production and use
PT2734538T (pt) * 2011-07-18 2018-08-02 Iba Gmbh Processo para corar, de forma reversível, uma célula-alvo
WO2013124474A2 (en) * 2012-02-23 2013-08-29 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials

Similar Documents

Publication Publication Date Title
JP2017514481A5 (enExample)
JP6475630B2 (ja) ストレプトアビジン突然変異タンパク質およびそれらを使用する方法
RU2016144724A (ru) Способы, наборы и устройство для размножения популяции клеток
JP2017513524A5 (enExample)
CN102892885B (zh) IgA结合性肽以及利用其的IgA的纯化
TW200940989A (en) A method for characterization of a recombinant polyclonal protein
CN106662584A (zh) 分离靶细胞的方法
Mukherjee et al. A new versatile immobilization tag based on the ultra high affinity and reversibility of the calmodulin–calmodulin binding peptide interaction
RU2018138782A (ru) Антитела к фактору ix padua
JP5042237B2 (ja) 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用
JP2019527033A5 (enExample)
JP2005507648A5 (enExample)
CN104597256A (zh) 一条与牛病毒性腹泻病毒e2蛋白相结合的多肽序列及其应用
JP2003344404A (ja) 核酸選別用センサーチップ
Cai et al. Peptoid ligands that bind selectively to phosphoproteins
JP2023541807A (ja) Mhciペプチド結合の特徴づけのためのアッセイおよび試薬
Geumann et al. A sandwich enzyme-linked immunosorbent assay for the quantification of insoluble membrane and scaffold proteins
WO2013081037A1 (ja) IgA結合性ペプチド及びそれによるIgAの精製
US11796545B2 (en) Methods and kits for determining binding sites
JP2017533913A5 (enExample)
JP6245688B2 (ja) IgY特異的結合ペプチド及びそれによるIgYの精製法
Säll et al. Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach
WO2011068538A2 (en) General method for generating ultra-high affinity binding proteins
Shcherbakova et al. The Influence of biotinylation of 2F5 antibody on peptide selection from the combinatorial phage library
JPWO2023277122A5 (enExample)